New medicine for diabetes and weight lossImage Credit Source: Social Media
Mounjaro kwikpen price in india: New types of machines and equipment have come for diseases in the markets, from which any disease can be done from testing to monitring. Eli Lilly the company has launched its popular drug Mountpatide in a new form in India. Let us tell you that Eli Lilly is a famous healthcare company. Mountzaro from this company will learn further about the new form in India. What is this medicine, in which disease does it work and what is the price?
World’s famous healthcare company Eli lilly Mount your medicine (Tirzepatide) Now new in India Kwikpen Has launched in form. Its initial price has been kept ₹ 14,000. This drug helps in both type-2 diabetes and weight loss. The funny thing is that exactly two days ago, its collision company Novo Nordisk had launched its medicine in India. That is, now there will be a direct contest in the treatment of diabetes and weight loss.
This is the same drug that is used for both type-2 diabetes and obesity, and now the company has taken a new step to make it accessible to all in the country. Let us tell you that Mountzaro has launched this medicine in the form of an injector pen. Which will monitor diabetes and control blood sugar.
Mountzaro Kwikpen’s specialty
- This pen comes in 6 different doses. From 2.5 mg to 15 mg.
- The price of 2.5 mg dose is ₹ 14,000.
- The price of 5 mg is ₹ 17,500.
- The price of 7.5 Mg and 10 Mg is ₹ 22,000.
- The price of 12.5 mg and 15 mg dose is ₹ 27,500.
Experts say that Mountzaro prices are attractive and competing in India. Healthcare analyst named Vishal Machanda has also said that Mountzaro is better than Vagovi.
How this medicine works
Mountzaro GLP-1 receptor comes in drugs called agonists. It controls blood sugar, slows down digestion and reduces appetite. By taking this, people do not feel hungry for a long time, feel full of full, which helps in weight loss.
Sale status in India
In March 2025, Lilly started selling it in India in 2.5 mg and 5 mg. After this, the demand increased so much that in July its sales doubled compared to the previous month. Now doctors and patients have options for two big companies in the treatment of weight and diabetes.
Important things of mountzaro
The initial price of ₹ 14,000 can make it accessible to many people. Both obesity and diabetes are growing rapidly in India, so this launch is a big step. In the coming time, it will be interesting to see how popular Mountzaro is in the Indian market and whether it is able to leave the vegovi behind or not.